Biochemical Particle Dynamics

ApoB vs. LDL-C: The Particle Count Reality

Standard cholesterol panels measure the weight of cargo, not the number of vehicles on the road. Simulate how discordant atherogenic particle counts drive arterial plaque accumulation.

Why does Apolipoprotein B (ApoB) predict vascular health better than LDL-C? Every single atherogenic particle—including LDL, VLDL, and IDL—carries exactly one ApoB molecule. When insulin resistance creates small, dense LDL particles, a person can have completely "normal" LDL-C while having dangerously elevated ApoB particles colliding with the arterial endothelium.
Interactive Lipid Subfraction Studio

Adjust Your Cardiovascular Biomarkers

Drag the sliders below or choose a clinical preset to simulate vascular collision dynamics.

Clinical Presets:
⚠️
Discordant Particle Hazard: Normal LDL-C with Elevated ApoB

Your standard LDL-C of 95 mg/dL appears "normal" on conventional physicals, but your elevated ApoB of 110 mg/dL reveals a high volume of small dense particles penetrating the vascular wall.

Discordant High Risk
Conventional Metric
95 mg/dL
Optimal: < 80 Conventional: < 100 High: > 130
True Particle Count
110 mg/dL
Integrix Optimal: < 65 Moderate: 65–90 High Risk: > 90
Metabolic Accelerator
11.0 µIU/mL
Optimal: 2.0–5.0 Gray Zone: 5.1–10.0 Insulin Lock: > 10.0
Particle Size Proxy
3.2 Ratio
Optimal Pattern A: < 1.5 Mixed: 1.5–2.5 Dense Pattern B: > 2.5

Vascular Traffic & Endothelial Penetration Model

Traffic Density: High Small Dense Particle Collision
Arterial Endothelium (Intima)
Vascular Smooth Muscle Layer
⚡
Atherogenic Particle Burden Elevated (Pattern B)

High concentration of atherogenic ApoB particles circulating per deciliter of plasma.

🎯
Vascular Collision Multiplier 2.4x Baseline

Increased probability of subendothelial particle entrapment and macrophage oxidation.

🩸
Metabolic Phenotype Insulin Resistant Drift

Hepatic VLDL overproduction driving dense particle remodeling.

🛡️
Integrix Clinical Action Rung 3 Metabolic Precision

Stabilize fasting insulin below 5.0 µIU/mL, sequence dietary fiber, and clear hepatic fat.

Why Dr. Status Quo Misses 50% of Cardiovascular Risk

Standard blood tests check Total Cholesterol and calculated LDL-C because they are cheap to run. Here is the clinical comparison between the status quo and functional precision cardiology.

Diagnostic Parameter Conventional Lipid Panel Integrix Precision Healthspan
Primary Target Calculated LDL-C (Weight of cholesterol cargo) ApoB Particle Concentration (Total number of atherogenic particles)
Optimal Range < 100 mg/dL < 65 mg/dL (or < 50 for primary longevity)
Particle Sizing Not measured (Assumes all particles are identical) TG/HDL Ratio & NMR Lipoprofile (Pattern A vs. dense Pattern B)
Root Cause Drivers Dietary saturated fat blamed solely Fasting Hyperinsulinemia, endothelial glycation & systemic inflammation (hs-CRP)
Intervention Approach Wait until 10-year risk exceeds threshold for lifetime statin Rung 3 (Vitality by Design™): Reverse insulin resistance, eliminate glycemic friction, optimize vascular endothelium

Stop guessing your vascular health. Know your numbers.

Integrix Health evaluates ApoB, advanced lipid subfractions, fasting insulin, and cardiovascular genomics in Rung 3 (Vitality by Design™). Schedule a free 30-minute discovery consultation with Dr. Paul M. Bekkum.

Schedule Your Free Discovery Session Explore Functional Lab Ranges